Skip to main content
Normal View

Hospital Waiting Lists

Dáil Éireann Debate, Tuesday - 27 July 2021

Tuesday, 27 July 2021

Questions (1613)

James Lawless

Question:

1613. Deputy James Lawless asked the Minister for Health if the case of a person (details supplied) will be examined and expedited; and if he will make a statement on the matter. [34490/21]

View answer

Written answers

I refer to the matter which has been raised by the Deputy. The Cross-Border Directive (CBD) and the analogous Northern Ireland Planned Healthcare Scheme (NIPHS) allows for patients that are normally resident in Ireland and availing of public health services to avail of treatment in another EU/EEA Member State, for the CBD, or Northern Ireland, for the NIPHS. Reimbursement under these schemes is made at the lesser of either the cost of the treatment in Ireland, or the cost in the other State. Details are available from the HSE's CBD National Contact Point (NCP). The CBD is designed to assist the mobility of patients by reimbursing them for healthcare accessed in Member States other than their Member State of Affiliation across the EU/EEA.

There is no scheme available for the reimbursement of treatment costs where a patient has accessed private care within the State.

Top
Share